Elanco Animal Health Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名24/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價25.15。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Elanco Animal Health Inc評分
相關信息
行業排名
24 / 158
全市場排名
74 / 4582
所屬行業
藥品
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
16
分析師
買入
評級
25.154
目標均價
+15.97%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Elanco Animal Health Inc亮點
亮點風險
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
公司代碼ELAN
公司Elanco Animal Health Inc
CEOSimmons (Jeffrey N)
網址https://www.elanco.com/
常見問題
Elanco Animal Health Inc(ELAN)的當前股價是多少?
Elanco Animal Health Inc(ELAN)的當前股價是 22.305。
Elanco Animal Health Inc 的股票代碼是什麼?
Elanco Animal Health Inc的股票代碼是ELAN。
Elanco Animal Health Inc股票的52週最高點是多少?
Elanco Animal Health Inc股票的52週最高點是23.700。
Elanco Animal Health Inc股票的52週最低點是多少?
Elanco Animal Health Inc股票的52週最低點是8.020。
Elanco Animal Health Inc的市值是多少?
Elanco Animal Health Inc的市值是11.08B。
Elanco Animal Health Inc的淨利潤是多少?
Elanco Animal Health Inc的淨利潤為338.00M。
現在Elanco Animal Health Inc(ELAN)的股票是買入、持有還是賣出?
根據分析師評級,Elanco Animal Health Inc(ELAN)的總體評級為買入,目標價格為25.154。
Elanco Animal Health Inc(ELAN)股票的每股收益(EPS TTM)是多少
Elanco Animal Health Inc(ELAN)股票的每股收益(EPS TTM)是0.072。